Dissecting the stromal signalingandregulation of myeloid cells and memory effector T cells in pancreatic cancer

Alex B. Blair, Victoria M. Kim, Stephen T. Muth, May Tun Saung, Nathalie Lokker, Barbara Blouw, Todd D. Armstrong, Elizabeth M. Jaffee, Takahiro Tsujikawa, Lisa M. Coussens, Jin He, Richard A. Burkhart, Christopher L. Wolfgang, Lei Zheng

Research output: Contribution to journalArticle

Abstract

Purpose: Myeloid cells are a prominent immunosuppressive component within the stroma of pancreatic ductal adenocarcinoma (PDAC). Previously, targeting myeloid cells has had limited success. Here, we sought to target the myeloid cells through modifying a specific stromal component. Experimental Design: A murine model of metastatic PDAC treated with an irradiated whole-cell PDAC vaccine and PDAC specimens from patients treated with the same type of vaccine were used to assess the immune-modulating effect of stromal hyaluronan (HA) degradation by PEGPH20. Results:Targeting stroma by degradingHAwithPEGPH20 in combination with vaccine decreases CXCL12/CXCR4/ CCR7 immunosuppressive signaling axis expression in cancer-associated fibroblasts, myeloid, and CD8+ T cells, respectively. This corresponds with increased CCR7+ effector memory T-cell infiltration, an increase in tumor-specific IFNg, and improved survival. In the stroma of human PDACs treated with the same vaccine, decreased stromal CXCR4 expression significantly correlated with decreased HA and increased cytotoxic activities, suggesting CXCR4 is an important therapeutic target. Conclusions: This study represents the first to dissect signaling cascades following PDAC stroma remodeling via HA depletion, suggesting this not only overcomes a physical barrier for immune cell trafficking, but alters myeloid function leading to downstream selective increases in effector memory T-cell infiltration and antitumor activity.

Original languageEnglish (US)
Pages (from-to)5351-5363
Number of pages13
JournalClinical Cancer Research
Volume25
Issue number17
DOIs
StatePublished - Sep 1 2019

Fingerprint

Myeloid Cells
Pancreatic Neoplasms
Adenocarcinoma
T-Lymphocytes
Hyaluronic Acid
Vaccines
Immunosuppressive Agents
Combined Vaccines
Architectural Accessibility
Research Design
Survival
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Dissecting the stromal signalingandregulation of myeloid cells and memory effector T cells in pancreatic cancer. / Blair, Alex B.; Kim, Victoria M.; Muth, Stephen T.; Saung, May Tun; Lokker, Nathalie; Blouw, Barbara; Armstrong, Todd D.; Jaffee, Elizabeth M.; Tsujikawa, Takahiro; Coussens, Lisa M.; He, Jin; Burkhart, Richard A.; Wolfgang, Christopher L.; Zheng, Lei.

In: Clinical Cancer Research, Vol. 25, No. 17, 01.09.2019, p. 5351-5363.

Research output: Contribution to journalArticle

Blair, Alex B. ; Kim, Victoria M. ; Muth, Stephen T. ; Saung, May Tun ; Lokker, Nathalie ; Blouw, Barbara ; Armstrong, Todd D. ; Jaffee, Elizabeth M. ; Tsujikawa, Takahiro ; Coussens, Lisa M. ; He, Jin ; Burkhart, Richard A. ; Wolfgang, Christopher L. ; Zheng, Lei. / Dissecting the stromal signalingandregulation of myeloid cells and memory effector T cells in pancreatic cancer. In: Clinical Cancer Research. 2019 ; Vol. 25, No. 17. pp. 5351-5363.
@article{0d3ef67f818a42c4b3334ed12439c1cb,
title = "Dissecting the stromal signalingandregulation of myeloid cells and memory effector T cells in pancreatic cancer",
abstract = "Purpose: Myeloid cells are a prominent immunosuppressive component within the stroma of pancreatic ductal adenocarcinoma (PDAC). Previously, targeting myeloid cells has had limited success. Here, we sought to target the myeloid cells through modifying a specific stromal component. Experimental Design: A murine model of metastatic PDAC treated with an irradiated whole-cell PDAC vaccine and PDAC specimens from patients treated with the same type of vaccine were used to assess the immune-modulating effect of stromal hyaluronan (HA) degradation by PEGPH20. Results:Targeting stroma by degradingHAwithPEGPH20 in combination with vaccine decreases CXCL12/CXCR4/ CCR7 immunosuppressive signaling axis expression in cancer-associated fibroblasts, myeloid, and CD8+ T cells, respectively. This corresponds with increased CCR7+ effector memory T-cell infiltration, an increase in tumor-specific IFNg, and improved survival. In the stroma of human PDACs treated with the same vaccine, decreased stromal CXCR4 expression significantly correlated with decreased HA and increased cytotoxic activities, suggesting CXCR4 is an important therapeutic target. Conclusions: This study represents the first to dissect signaling cascades following PDAC stroma remodeling via HA depletion, suggesting this not only overcomes a physical barrier for immune cell trafficking, but alters myeloid function leading to downstream selective increases in effector memory T-cell infiltration and antitumor activity.",
author = "Blair, {Alex B.} and Kim, {Victoria M.} and Muth, {Stephen T.} and Saung, {May Tun} and Nathalie Lokker and Barbara Blouw and Armstrong, {Todd D.} and Jaffee, {Elizabeth M.} and Takahiro Tsujikawa and Coussens, {Lisa M.} and Jin He and Burkhart, {Richard A.} and Wolfgang, {Christopher L.} and Lei Zheng",
year = "2019",
month = "9",
day = "1",
doi = "10.1158/1078-0432.CCR-18-4192",
language = "English (US)",
volume = "25",
pages = "5351--5363",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "17",

}

TY - JOUR

T1 - Dissecting the stromal signalingandregulation of myeloid cells and memory effector T cells in pancreatic cancer

AU - Blair, Alex B.

AU - Kim, Victoria M.

AU - Muth, Stephen T.

AU - Saung, May Tun

AU - Lokker, Nathalie

AU - Blouw, Barbara

AU - Armstrong, Todd D.

AU - Jaffee, Elizabeth M.

AU - Tsujikawa, Takahiro

AU - Coussens, Lisa M.

AU - He, Jin

AU - Burkhart, Richard A.

AU - Wolfgang, Christopher L.

AU - Zheng, Lei

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Purpose: Myeloid cells are a prominent immunosuppressive component within the stroma of pancreatic ductal adenocarcinoma (PDAC). Previously, targeting myeloid cells has had limited success. Here, we sought to target the myeloid cells through modifying a specific stromal component. Experimental Design: A murine model of metastatic PDAC treated with an irradiated whole-cell PDAC vaccine and PDAC specimens from patients treated with the same type of vaccine were used to assess the immune-modulating effect of stromal hyaluronan (HA) degradation by PEGPH20. Results:Targeting stroma by degradingHAwithPEGPH20 in combination with vaccine decreases CXCL12/CXCR4/ CCR7 immunosuppressive signaling axis expression in cancer-associated fibroblasts, myeloid, and CD8+ T cells, respectively. This corresponds with increased CCR7+ effector memory T-cell infiltration, an increase in tumor-specific IFNg, and improved survival. In the stroma of human PDACs treated with the same vaccine, decreased stromal CXCR4 expression significantly correlated with decreased HA and increased cytotoxic activities, suggesting CXCR4 is an important therapeutic target. Conclusions: This study represents the first to dissect signaling cascades following PDAC stroma remodeling via HA depletion, suggesting this not only overcomes a physical barrier for immune cell trafficking, but alters myeloid function leading to downstream selective increases in effector memory T-cell infiltration and antitumor activity.

AB - Purpose: Myeloid cells are a prominent immunosuppressive component within the stroma of pancreatic ductal adenocarcinoma (PDAC). Previously, targeting myeloid cells has had limited success. Here, we sought to target the myeloid cells through modifying a specific stromal component. Experimental Design: A murine model of metastatic PDAC treated with an irradiated whole-cell PDAC vaccine and PDAC specimens from patients treated with the same type of vaccine were used to assess the immune-modulating effect of stromal hyaluronan (HA) degradation by PEGPH20. Results:Targeting stroma by degradingHAwithPEGPH20 in combination with vaccine decreases CXCL12/CXCR4/ CCR7 immunosuppressive signaling axis expression in cancer-associated fibroblasts, myeloid, and CD8+ T cells, respectively. This corresponds with increased CCR7+ effector memory T-cell infiltration, an increase in tumor-specific IFNg, and improved survival. In the stroma of human PDACs treated with the same vaccine, decreased stromal CXCR4 expression significantly correlated with decreased HA and increased cytotoxic activities, suggesting CXCR4 is an important therapeutic target. Conclusions: This study represents the first to dissect signaling cascades following PDAC stroma remodeling via HA depletion, suggesting this not only overcomes a physical barrier for immune cell trafficking, but alters myeloid function leading to downstream selective increases in effector memory T-cell infiltration and antitumor activity.

UR - http://www.scopus.com/inward/record.url?scp=85071783360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071783360&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-18-4192

DO - 10.1158/1078-0432.CCR-18-4192

M3 - Article

C2 - 31186314

AN - SCOPUS:85071783360

VL - 25

SP - 5351

EP - 5363

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 17

ER -